Oculis Holding Ag Revenue per Employee (OCS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Oculis Holding Ag  (NASDAQ: OCS)
 

Oculis Holding Ag's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 85.72% in the fourth quarter 2025, year on year to cumulative value of $1 million, Oculis Holding Ag's revenue per employee grew on a trailing twelve months basis to $ 24,121. The productivity of Oculis Holding Ag's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 560 other companies have achieved higher revenue per employee. While Oculis Holding Ag's total ranking has deteriorated compared to the previous quarter from 0 to 3896. Oculis Holding Ag has 60 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OCS Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 85.72 % - - - -20.76 %
Sales per Employee (TTM) $ 24,121 12,988 12,988 12,988 12,988
OCS's Total Ranking # 3896 # 0 # # #
Seq. Revenue Change - - - - -

OCS Company Profile >> Back to OCS Efficiency Comparisons >> Compare OCS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 210
Healthcare Sector # 561
Overall Market # 3896

Revenue per Employee Statistics
High Average Low
$ 19,983 $ 15,333 $ 11,433
(Dec 31 2025)   (Dec 31 2024)



Financial Statements
Oculis Holding Ag's Revenue MRQ $ 1 Millions Visit OCS's Income Statement
Oculis Holding Ag's Revenues TTM $ 1 Millions Visit OCS's aggregate revenue growth
What are OCS's Sales? Visit OCS's Sales by Segment




Other Ratios
Oculis Holding Ag's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
OCS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for OCS's Competitors
Revenue per Employee for OCS's Suppliers
Revenue per Employee for OCS's Customers

You may also want to know
OCS's Sales Growth Rates OCS's Pe Price to earnings ratio OCS's Receivables Turnover Ratio OCS's Stock Quote
OCS's Net Income Growth Rates OCS's Ps Price to Sales ratio OCS's Sales per Employee OCS's Asset Turnover Ratio
OCS's Net Margin OCS's Pb Price to Book ratio OCS's Financial Strength Ratios OCS's Dividend Payout Ratio
Date modified: 2026-09-10T03:13:29+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Fate Therapeutics Inc   41,279.50 $ 6.646  Million 161 
Safe Pro Group Inc   40,445.40 $ 0.607  Million 15 
Astrotech Corp  39,966.67 $ 1.199  Million 30 
Xortx Therapeutics inc   39,722.53 $ 0.596  Million 15 
Puretech Health Plc  39,483.05 $ 4.659  Million 118 
Scientific Industries Inc   38,450.99 $ 7.767  Million 202 
Upstream Bio Inc   38,053.33 $ 2.854  Million 75 
Ocugen Inc   38,043.10 $ 4.413  Million 116 
Nexalin Technology Inc   37,705.88 $ 0.302  Million 8 
Cartesian Therapeutics Inc   37,293.33 $ 2.797  Million 75 
Atrium Therapeutics Inc   36,702.54 $ 18.755  Million 511 
Petvivo Holdings Inc   35,965.32 $ 0.791  Million 22 
Scisparc Ltd  34,240.00 $ 0.856  Million 25 
Vivos Inc  34,189.50 $ 0.068  Million 2 
Rafael Holdings Inc  33,478.26 $ 0.770  Million 23 
Dbv Technologies S a   33,429.41 $ 5.683  Million 170 
Sintx Technologies Inc   31,812.50 $ 1.018  Million 32 
Prime Medicine Inc   31,726.03 $ 4.632  Million 146 
Longeveron Inc   31,552.63 $ 1.199  Million 38 
Addus Homecare Corp  28,067.55 $ 1,421.874  Million 50,659 
Nakamoto Inc   28,020.23 $ 1.821  Million 65 
Aligos Therapeutics Inc   26,658.54 $ 2.186  Million 82 
Biorestorative Therapies Inc   25,692.86 $ 0.360  Million 14 
Envoy Medical Inc   24,100.00 $ 0.241  Million 10 
Silo Pharma Inc  24,058.67 $ 0.072  Million 3 
Volitionrx Limited  23,031.79 $ 1.727  Million 75 
Galmed Pharmaceuticals Ltd   22,522.52 $ 2.500  Million 111 
Bioxcel Therapeutics Inc   22,137.93 $ 0.642  Million 29 
Dianthus Therapeutics Inc   22,130.43 $ 2.036  Million 92 
Mangoceuticals Inc   20,728.23 $ 0.456  Million 22 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.